Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 entry and removed the funding-status notice and Revision: v3.4.1 from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a government funding lapse notice and Revision: v3.4.1; removed Revision: v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page adds a Show glossary option and clarifies color-coding for additions and deletions. The revision label was updated from v3.3.4 to v3.4.0, and the 'No FEAR Act data' text was removed.SummaryDifference0.8%

- Check35 days agoChange DetectedNew entry on 2026-01-20 adds a Study Status update. The 2025-01-17 record is removed, updating the version history.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page history. This reflects a minor software update to the site.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.2%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.